focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.50
Bid: 23.00
Ask: 24.00
Change: -1.00 (-4.08%)
Spread: 1.00 (4.348%)
Open: 24.00
High: 24.25
Low: 23.50
Prev. Close: 24.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

20 May 2020 11:00

RNS Number : 4911N
Renalytix AI PLC
20 May 2020
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PMEKKKBKKBKDKPB
Date   Source Headline
6th Aug 20197:00 amRNSExpansion of Chronic Kidney Disease Advisory Board
31st Jul 20194:30 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSThomas McLain Appointed as President and CCO
23rd Jul 20196:23 pmRNSResult of Placing & Total Voting Rights
23rd Jul 20197:01 amRNSProposed Placing to raise £12.0m (c.US$15.0m)
12th Jul 20197:00 amRNSUS Exec Order on Advancing American Kidney Health
9th Jul 20197:00 amRNSPositive Interim Results for Validation Study
8th Jul 20197:00 amRNSFractalDx Positive Results Published in JASN
1st Jul 20197:00 amRNSUS CPT® Code Granted for KidneyIntelX(TM)
7th Jun 20197:00 amRNSPositive results from FractalDx study published
4th Jun 20197:00 amRNSKidneyIntelX commercial scale production milestone
28th May 20197:00 amRNSCLIA Certificate Number issued for Renalytix Lab
21st May 20197:00 amRNSExpansion of FractalDx core investigator group
7th May 20197:00 amRNSUniversity Medical Center Groningen collaboration
2nd May 20192:05 pmRNSSecond Price Monitoring Extn
2nd May 20192:00 pmRNSPrice Monitoring Extension
2nd May 20197:00 amRNSFDA grants Breakthrough Device designation
26th Apr 20196:20 pmRNSAcquisition of further interest in Renalytix AI
26th Apr 20195:42 pmRNSDirector/PDMR Shareholding
2nd Apr 201912:55 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSPublication of confirmation study results
25th Mar 20197:00 amRNSHalf-year Report
22nd Mar 20197:00 amRNSRenalytixAI Forms Core Investigator Group
12th Mar 20197:00 amRNSInvestor briefing
14th Feb 20197:00 amRNSAppointment of Nomad and Joint Broker
13th Feb 20197:00 amRNSJoint venture partnership agreement with AKESOgen
6th Feb 20197:00 amRNSRenalytixAI Expands Leadership Team
23rd Jan 20197:00 amRNSInitiates Clinical Validation Study
21st Jan 20197:00 amRNSClarification re. lock-up restrictions
2nd Jan 20197:00 amRNSExercise of Option for Exclusive License
20th Dec 20185:20 pmRNSDirector/PDMR Shareholding
20th Dec 20187:01 amRNSPlanned appointment of joint broker & of NOMAD
19th Dec 20186:28 pmRNSDirector Dealing
17th Dec 20181:30 pmRNSHolding(s) in Company
9th Nov 201810:30 amRNSHolding(s) in Company
8th Nov 20184:50 pmRNSHolding(s) in Company
8th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSRENX Admission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.